Risk stratification for early-onset fetal growth restriction in women with abnormal serum biomarkers: a retrospective cohort study

Abstract Abnormal maternal serum biomarkers (AMSB), identified through the aneuploidy screening programme, are frequent incidental findings in pregnancy. They are associated with fetal growth restriction (FGR), but previous studies have not examined whether this association is with early-onset (<...

Full description

Bibliographic Details
Main Authors: L. Ormesher, L. Warrander, Y. Liu, S. Thomas, L. Simcox, G. C. S. Smith, J. E. Myers, E. D. Johnstone
Format: Article
Language:English
Published: Nature Publishing Group 2020-12-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-020-78631-5